Clinical Trials
36 trialsA Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
City of Hope Medical Center
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
GeoVax, Inc.
Covid-19 Vaccine Responsiveness in MM and Waldenstrom
Massachusetts General Hospital
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Scripps Translational Science Institute
FIL_FollVax22
Fondazione Italiana Linfomi - ETS
STRONGER
The George Institute
MoVeUP
IDeA States Pediatric Clinical Trials Network
Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)
Masonic Cancer Center, University of Minnesota
An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY
Klinikum Bremen-Mitte, gGmbH
COVID-19 and Childhood Cancer
Karolinska Institutet
SPLaT-19
Keele University
SARS-CoV-2 Donor-Recipient Immunity Transfer
City of Hope Medical Center
PACE-CLL
Sunnybrook Health Sciences Centre
Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19
Direct Biologics, LLC
Rhu-pGSN for Severe Covid-19 Pneumonia
BioAegis Therapeutics Inc.
Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness
Immune Biosolutions Inc
The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19
Huashan Hospital
A Real-World Study of COVID-19 Infection in Patients With Malignant Lymphomas Participating in Clinical Trials
Sun Yat-sen University
SABRE
Imperial College Healthcare NHS Trust
A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19
Vascular Biogenics Ltd. operating as VBL Therapeutics
CHRONOS19
National Research Center for Hematology, Russia
CDK6COV
biotx.ai GmbH
COVID19-hematological Malignancies: the Italian Hematology Alliance
Ospedale di Circolo - Fondazione Macchi
PERN-COVID-19
University of Calgary
POLYCOR
Nantes University Hospital
AutoCOVID-19
Uppsala University
Emotional and Physical Health Status of Adults
Pamukkale University
Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19
Histogen
LYMPHO-Cov-2
Versailles Hospital
COVID19REHAB
Centro Universitário de Anapolis
PlaSenTer
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
PRO-CARF
Hospital Civil de Guadalajara
Clinical Characteristics of Patients With Leukemia and COVID-19
Hospital General de Mexico
A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole
AstraZeneca
CLOVIS
Bicetre Hospital